Press and media

Dr. Ali Tinazli’s post at the Forbes magazine about “Why Knowledge Is Power In The Treatment Of Obesity”

lifespin GmbH announced as inaugural member of the Wyss Diagnostics Accelerator (Wyss DxA) Industrial Participant Program (IPP) at Harvard University.

An interview by 5-HT Digital Hub Chemistry & Health with Dr. Ali Tinazli

lifespin’s agreement with Medical University Graz which garants access to more than 25,000 longitudinal blood samples

Dr. Ali Tinazli’s first post at the Forbes magazine about “The Bio Revolution Brings Innovation For Precision Diagnostics”

Metabolomics, an emerging clinical modality, enabling precision, personalized medicine

Metabolomics can measure the actual physiological state of an individual, providing new health insights

BOSTON (MA), April 12th, 2022 — Lifespin GmbH, a deep data company that is mapping human health and building an innovative health diagnostic testing platform based on metabolomics, announced today that it has formally established a U.S. entity, Lifespin, Inc., incorporated in Delaware, and based initially in Boston (MA) to accelerate the company’s access to U.S. healthcare market opportunities, clinical research partners, and investors. “The establishment of our U.S. corporate entity represents an important step in our development here in the United States and will be followed by expanded business …

Lifespin Establishes U.S. Corporate Entity in Anticipation of Market Expansion Read More »

Das Regensburger Unternehmen Lifespin digitalisiert Stoffwechselproben und wagt heuer den Sprung in die USA – Auch die Harvard University ist bei der Entwicklung beteiligt

Lifespin GmbH Secures €2.5M Bridge Financing to Further Build its AI-Enabled
Metabolomics-Based Differential Diagnosis Panel for Neurological Diseases